Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus®

LEXXW : 0.0012 (-77.36%)
LEXX : 0.6990 (-2.71%)
Lexaria Bioscience Expands Strategic Outreach and Secures New Patents

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Lexaria Bioscience...

LEXX : 0.6990 (-2.71%)
Fed Meeting, U.S. Jobs in Focus for This Week

Tuesday U.S. Economic Lookahead NFIB optimism index (June) Consumer credit (May) ...

AZZ : 135.98 (+1.18%)
SAR : 23.16 (-1.24%)
CAG : 19.25 (+2.78%)
MTY.TO : 41.40 (-0.81%)
UNTY : 53.19 (-0.30%)
LEXX : 0.6990 (-2.71%)
PENG : 20.78 (+1.42%)
DAL : 65.70 (-6.82%)
BSET : 14.97 (+0.47%)
LEVI : 22.16 (-1.77%)
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock

KELOWNA, BC / ACCESS Newswire / April 28, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the closing...

LEXXW : 0.0012 (-77.36%)
LEXX : 0.6990 (-2.71%)
Lexaria Announces $2 Million Registered Direct Offering of Common Stock

KELOWNA, BC / ACCESS Newswire / April 25, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it...

LEXXW : 0.0012 (-77.36%)
LEXX : 0.6990 (-2.71%)
Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology

Pfizer and Eli Lilly reporting significant - and opposing - news in the GLP-1 industry

LEXXW : 0.0012 (-77.36%)
LEXX : 0.6990 (-2.71%)
Lexaria Updates its Ongoing Human Study GLP-1-H24-4

Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss

LEXXW : 0.0012 (-77.36%)
LEXX : 0.6990 (-2.71%)
Lexaria's Human GLP-1 Study #5 Begins Dosing

Head-to-head human study comparing traditional injected liraglutide to first-ever oral DehydraTECH-liraglutide

LEXXW : 0.0012 (-77.36%)
LEXX : 0.6990 (-2.71%)
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®

LEXXW : 0.0012 (-77.36%)
LEXX : 0.6990 (-2.71%)
The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

Lexaria executing a triple-pronged strategy in obesity and diabetes

LEXXW : 0.0012 (-77.36%)
LEXX : 0.6990 (-2.71%)

Barchart Exclusives

Jobs, Geopolitics and Other Key Things to Watch this Week
Markets enter March following another losing week that saw airline stocks hammered after President Trump's threats against Iran escalated Middle East tensions, while a surprisingly hot inflation reading dragged equities lower as February trading wrapped up. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar